Literature DB >> 27466947

Compound Design by Fragment-Linking.

Osamu Ichihara1, John Barker1, Richard J Law1, Mark Whittaker2.   

Abstract

The linking together of two fragment compounds that bind to distinct protein sub-sites can lead to a superadditivity of binding affinities, in which the binding free energy of the linked fragments exceeds the simple sum of the binding energies of individual fragments (linking coefficient E<1). However, a review of the literature shows that such events are relatively rare and, in the majority of the cases, linking coefficients are far from optimal being much greater than 1. It is critical to design a linker that does not disturb the original binding poses of each fragment in order to achieve successful linking. However, such an ideal linker is often difficult to design and even more difficult to actually synthesize. We suggest that the chance of achieving successful fragment linking can be significantly improved by choosing a fragment pair that consists of one fragment that binds by strong H-bonds (or non-classical equivalents) and a second fragment that is more tolerant of changes in binding mode (hydrophobic or vdW binders). We also propose that the fragment molecular orbital (FMO) calculations can be used to analyse the nature of the binding interactions of the fragment hits for the selection of fragments for evolution, merging and linking in order to optimize the chance of success.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  Drug discovery; Fragment linking; Fragment molecular orbital; Superadditivity; X-ray crystallography

Year:  2011        PMID: 27466947     DOI: 10.1002/minf.201000174

Source DB:  PubMed          Journal:  Mol Inform        ISSN: 1868-1743            Impact factor:   3.353


  20 in total

1.  A fragment-based approach to the SAMPL3 Challenge.

Authors:  John L Kulp; Seth N Blumenthal; Qiang Wang; Richard L Bryan; Frank Guarnieri
Journal:  J Comput Aided Mol Des       Date:  2012-05       Impact factor: 3.686

2.  Extending the Detection Limit in Fragment Screening of Proteins Using Reverse Micelle Encapsulation.

Authors:  Brian Fuglestad; Nicole E Kerstetter; Sabrina Bédard; A Joshua Wand
Journal:  ACS Chem Biol       Date:  2019-10-03       Impact factor: 5.100

3.  Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.

Authors:  Henrik Möbitz; Rainer Machauer; Philipp Holzer; Andrea Vaupel; Frédéric Stauffer; Christian Ragot; Giorgio Caravatti; Clemens Scheufler; Cesar Fernandez; Ulrich Hommel; Ralph Tiedt; Kim S Beyer; Chao Chen; Hugh Zhu; Christoph Gaul
Journal:  ACS Med Chem Lett       Date:  2017-02-14       Impact factor: 4.345

Review 4.  Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.

Authors:  Duncan E Scott; Andrew R Bayly; Chris Abell; John Skidmore
Journal:  Nat Rev Drug Discov       Date:  2016-04-11       Impact factor: 84.694

Review 5.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

6.  Diphenylpyrazoles as replication protein a inhibitors.

Authors:  Alex G Waterson; J Phillip Kennedy; James D Patrone; Nicholas F Pelz; Michael D Feldkamp; Andreas O Frank; Bhavatarini Vangamudi; Elaine M Souza-Fagundes; Olivia W Rossanese; Walter J Chazin; Stephen W Fesik
Journal:  ACS Med Chem Lett       Date:  2014-11-11       Impact factor: 4.345

Review 7.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

8.  Discovery of WD Repeat-Containing Protein 5 (WDR5)-MYC Inhibitors Using Fragment-Based Methods and Structure-Based Design.

Authors:  Selena Chacón Simon; Feng Wang; Lance R Thomas; Jason Phan; Bin Zhao; Edward T Olejniczak; Jonathan D Macdonald; J Grace Shaw; Caden Schlund; William Payne; Joy Creighton; Shaun R Stauffer; Alex G Waterson; William P Tansey; Stephen W Fesik
Journal:  J Med Chem       Date:  2020-04-09       Impact factor: 7.446

Review 9.  In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery.

Authors:  Lauro Ribeiro de Souza Neto; José Teófilo Moreira-Filho; Bruno Junior Neves; Rocío Lucía Beatriz Riveros Maidana; Ana Carolina Ramos Guimarães; Nicholas Furnham; Carolina Horta Andrade; Floriano Paes Silva
Journal:  Front Chem       Date:  2020-02-18       Impact factor: 5.221

10.  Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach.

Authors:  Andreas O Frank; Michael D Feldkamp; J Phillip Kennedy; Alex G Waterson; Nicholas F Pelz; James D Patrone; Bhavatarini Vangamudi; DeMarco V Camper; Olivia W Rossanese; Walter J Chazin; Stephen W Fesik
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.